The participation of representatives from India’s National Medical Commission (NMC) in the Federation of State Medical Boards (FSMB) 2026 Annual Meeting marks a significant advancement in international collaboration for medical regulation, education, and licensing.
The National Medical Commission (NMC) of India participated in the Federation of State Medical Boards (FSMB) 2026 Annual Meeting held from April 30 to May 2, 2026, in Baltimore, Maryland. This event reflects India’s commitment to strengthening global collaboration in the fields of medical regulation, education, and licensure.
The Indian delegation included Dr. M.K. Ramesh, President of the Medical Assessment and Rating Board (MARB); Dr. Raghav Langer, Secretary of the NMC; and Dr. Lokesh Edara, Past Chairman of the American Association of Physicians of Indian Origin (AAPI) Board of Trustees. Their involvement underscores the NMC’s intention to align with international best practices in healthcare regulation under the leadership of NMC Chairperson Dr. Abhijat Seth.
Focus on International Collaboration
During the conference, NMC representatives engaged in discussions regarding physician licensure frameworks, regulatory standards, and quality assurance mechanisms. This engagement provided a platform for exploring collaborative pathways with leading organizations including the FSMB, the Educational Commission for Foreign Medical Graduates (ECFMG), the National Board of Medical Examiners (NBME), and the AAPI.
Dr. Ramesh emphasized the importance of international collaboration, stating, “International collaboration is essential to ensuring that medical education and licensure systems remain robust, transparent, and globally relevant.” This sentiment underscores the growing recognition of the need for harmonized medical standards across borders.
Engagement with Medical Leaders
A key highlight of the meeting was the NMC delegation’s interaction with prominent leaders within the field of medical regulation. Notable figures included Dr. Humayun Chaudhry, President and CEO of FSMB; Dr. Peter J. Katsufrakis, President and CEO of NBME; and Dr. Eric Holmboe, President of ECFMG. These discussions facilitated the exchange of knowledge on evolving trends in competency-based assessment, physician mobility, and regulatory innovations.
Dr. Langer remarked, “Dialogue with global counterparts enables the continuous refinement of regulatory frameworks in line with emerging healthcare challenges.” This exchange is viewed as vital in adapting to the rapidly changing healthcare landscape.
Significance of FAIMER Collaboration
The NMC’s active role as a member of the International Association of Medical Regulatory Authorities (IAMRA) highlights the importance of such international engagements. The delegation connected with leadership from ECFMG, which oversees initiatives like the Foundation for Advancement of International Medical Education and Research (FAIMER).
India’s relationship with FAIMER is particularly significant; the country hosts four FAIMER Regional Institutes (FRIs) that have collectively produced 685 fellows as of 2023, accounting for roughly 42% of the global total of 1,633 FAIMER fellows. This achievement underlines India’s leadership in medical education capacity building.
As noted by one participant, “India’s investment in faculty development through FAIMER demonstrates a sustained commitment to excellence in medical education.” This investment is indicative of India’s broader strategy to enhance the quality of medical training and practice.
Historical Context of FSMB
The FSMB, established in 1912, has a rich history of advocating for high standards in physician licensure and regulatory practices aimed at safeguarding public health and safety. Its evolution, including the first independent annual meeting in 1982 in New Orleans, reflects a longstanding dedication to advancing regulatory practices across the United States.
The alignment of the NMC’s objectives with FSMB’s mission is further evidenced by recommendations from a Parliamentary Standing Committee on Health in India, which has encouraged the NMC to study and adopt international best practices to enhance the regulatory framework in India.
Insights from State Medical Boards
In addition to high-level engagements, the NMC delegation also met with members of various state medical boards across the United States, including Dr. Chaitanya Anand from Minnesota, Dr. S. Chetan Shah of New Jersey, Dr. Sreeni R. Gangasani from Georgia, and Dr. Harbhajan Ajrawat from Maryland. These discussions provided valuable insights into the operational frameworks of state-level regulatory models.
Dr. Edara commented, “Understanding the diversity of state medical board systems enriches our perspective and informs the development of adaptable regulatory strategies.” This understanding is crucial for the NMC as it works to refine its own regulatory approaches.
Bridging Clinical and Regulatory Domains
The delegation also met with Dr. George M. Abraham, Chief of Medicine at Saint Vincent Hospital in Worcester, Massachusetts, and a Professor of Medicine at the University of Massachusetts Medical School. This interaction bridged the domains of clinical leadership, academic medicine, and regulatory governance, enhancing the overall scope of the visit.
In conclusion, the NMC’s participation in the FSMB 2026 Annual Meeting is a significant step towards fostering global partnerships and strengthening regulatory systems. The engagement not only facilitated a rich exchange of knowledge but also reinforced the importance of harmonizing standards in an increasingly interconnected medical landscape. As articulated by the delegation, “Collaboration across regulatory bodies is indispensable for ensuring high-quality healthcare delivery worldwide.”
